What serious adverse reactions happened during this study?
The table below shows the serious adverse reactions that happened during the study. The numbers in parentheses are the number of participants who had an adverse reaction.
Serious adverse reactions
Dapagliflozin Placebo
Serious adverse reaction (out of 252 participants) (out of 249 participants)
Urinary tract infection 0.4% (1) 0.0% (0)
Abnormal heartbeat 0.4% (1) 0.0% (0)
None of the participants who took dapagliflozin died due to serious adverse reactions during the study.
None of the participants who took the placebo had serious adverse reactions during the study or died due to serious adverse reactions.
What adverse reactions happened during this study?
The most common adverse reaction was a urinary tract infection.
The table below shows the adverse reactions that happened in 2 or more participants during the study. There were other adverse reactions, but these happened in only 1 participant each. Some participants may have had more than 1 adverse reaction. The numbers in parentheses are the number of participants who had an adverse reaction.
Most common adverse reactions
Dapagliflozin Placebo
Adverse reaction (out of 252 participants) (out of 249 participants)
Urinary tract infection 1.6% (4) 0.8% (2)
Dizziness 1.2% (3) 0.0% (0)
Urinating more often than normal 1.2% (3) 0.0% (0)
Nausea 0.8% (2) 0.0% (0)
Genital yeast infection 0.8% (2) 0.0% (0)
High levels of a protein called creatinine in the blood 0.4% (1) 0.4% (1)
Low blood pressure 0.0% (0) 1.2% (3)
Rash 0.0% (0) 0.8% (2)